Alternative strategies to improve symptoms associated with OA are detailed. Your patients may have nothing more to lose than their discomfort. Pain Management Nursing
For the FDA Arthritis Advisory Committee, the injectable biologic canakinumab may be promising for a niche group of patients, but fears about long-term safety kept them from voting for its approval. br / iMedscape Medical News/i
Remission in early rheumatoid arthritis (RA) is more likely with intensive rather than conventional methotrexate treatment, according to a report in the November issue of the Annals of the Rheumatic Diseases. Reuters Health Information
Pamapimod, a p38 MAP kinase inhibitor, was less effective than methotrexate for rheumatoid arthritis (RA) in an international study. Reuters Health Information
This report attests to the benefit of direct-to-the-brain delivery of anti-cytokine therapies, which may result in rapid and sustained improvement in cognition, behaviour, and attentiveness. Journal of Neuroinflammation
A challenging case of a patient with a family history of autoimmune disease, who presented with evidence of type 1 autoimmune hepatitis, further complicated by polyarteritis nodosa. Southern Medical Journal
